Kanta Subbarao

Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine, Roberts, A., Subbarao, K., Vogel, L., Lamirande, E., Rose, J.K., Kapadia, S.U., Virology, 2005, 10.1016/j.virol.2005.06.016

Classical swine H1N1 influenza viruses confer cross protection from swine-origin 2009 pandemic H1N1 influenza virus infection in mice and ferrets, Subbarao, K., Matsuoka, Y., Lamirande, E.W., Santos, C., Chen, G.L., Min, J.-Y., Virology, 2010, 10.1016/j.virol.2010.09.009

Antibody pressure by a human monoclonal antibody targeting the 2009 pandemic H1N1 virus hemagglutinin drives the emergence of a virus with increased virulence in mice, Subbaraoa, K., Wilson, P.C., Ahmed, R., Yewdell, J.W., Zheng, N.-Y., Mccausland, M., Li, G.-M., Wrammert, J., Das, S.R., Wright, A., Vogel, L., O'Donnell, C.D., mBio, 2012, 10.1128/mBio.00120-12

Erratum: Nucleotide sequence changes in the polymerase basic protein 2 gene of temperature-sensitive mutants of influenza A virus (Virology (506- 510)), Murphy, B.R., Subbarao, E.K., Lawson, C.M., Virology, 1993, 10.1006/viro.1993.1379

Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS, Collins, P.L., Subbarao, K., Murphy, B.R., St Claire, M., Elkins, W.R., Vogel, L.N., Buchholz, U.J., Lamirande, E.W., Bukreyev, A., Lancet, 2004, 10.1016/S0140-6736(04)16501-X

Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans, Subbarao, K., Zaki, S., Butler, E., Vogel, L., Paddock, C., Roberts, A., Journal of Virology, 2005, 10.1128/JVI.79.9.5833-5838.2005

The attenuation phenotype conferred by the M gene of the influenza A/Ann Arbor/6/60 cold-adapted virus (H2N2) on the A/Korea/82 (H3N2) reassortant virus results from a gene constellation effect, Murphy, B.R., Treanor, J.J., Perkins, M., Subbarao, E.K., Virus Research, 1992, 10.1016/0168-1702(92)90098-T

The ongoing battle against influenza: The challenge of flu transmission., Subbarao, K., Lakdawala, S.S., Nature medicine, 2012

Mammalian adaptation in the PB2 gene of avian H5N1 influenza virus, Subbarao, K., Ghedin, E., DePasse, J.V., Toyoda, Y., Twaddle, A., Fitch, A., Santos, C., Min, J.-Y., Journal of Virology, 2013, 10.1128/JVI.01016-13

Comparison of different approaches to measuring influenza A virus-specific hemagglutination inhibition antibodies in the presence of serum inhibitors, Murphy, B.R., Clements, M.L., Ryan-Poirier, K., Kawaoka, Y., Subbarao, E.K., Journal of Clinical Microbiology, 1992

Soft-Tissue Infections Caused by Mycobacterium fortuitum Complex Following Penetrating Injury, Marks, M.I., Tarpay, M.M., Subbarao, E.K., American Journal of Diseases of Children, 1987, 10.1001/archpedi.1987.04460090095037

Glycosylation at 158N of the hemagglutinin protein and receptor binding specificity synergistically affect the antigenicity and immunogenicity of a live attenuated H5N1 A/Vietnam/1203/2004 vaccine virus in ferrets, Jin, H., Kemble, G., Subbarao, K., Cheng, X., Suguitan Jr., A.L., Zhou, H., Lu, B., Wang, W., Journal of Virology, 2010, 10.1128/JVI.00221-10

Use of single-gene reassortant viruses to study the role of avian influenza A virus genes in attenuation of wild-type human influenza A virus for squirrel monkeys and adult human volunteers, Murphy, B.R., London, W.T., Karron, R.A., Fries, L.F., Subbarao, E.K., Clements, M.L., Journal of Clinical Microbiology, 1992

Heparin Inhibits SARS-CoV-2 Replication in Human Nasal Epithelial Cells, Jessica, Kanta Subbarao, Paul Monagle, Gary P. Anderson, Michael W. Parker, Craig Morton, Phil Robinson, Damian Purcell, Vera Ignjatovic, Conor McCafferty, Randy Suryadinata, Leo Yi Yang Lee, Viruses, 2022, 10.3390/v14122620

Animal models and vaccines for SARS-CoV infection, Subbarao, K., Baric, R., Sheahan, T., Zaki, S.R., Guarner, J., Paddock, C.D., Jackson, J.P., Vogel, L., Lamirande, E.W., Roberts, A., Virus Research, 2008, 10.1016/j.virusres.2007.03.025

The temperature-sensitive and attenuation phenotypes conferred by mutations in the influenza virus PB2, PB1, and NP genes are influenced by the species of origin of the PB2 gene in reassortant viruses derived from influenza A/California/07/2009 and A/WSN/33 viruses, Subbarao, K., Godbout, R.A., Santos, C.P., Broadbent, A.J., Journal of Virology, 2014, 10.1128/JVI.02142-14

A live attenuated H7N7 candidate vaccine virus induces neutralizing antibody that confers protection from challenge in mice, ferrets, and monkeys, Subbarao, K., Kemble, G., Jin, H., Swayne, D., Lu, B., Matsuoka, Y., Vogel, L., Min, J.-Y., Journal of Virology, 2010, 10.1128/JVI.01305-10

Avian influenza virus glycoproteins restrict virus replication and spread through human airway epithelium at temperatures of the proximal airways, Pickles, R.J., Barclay, W.S., Subbarao, K., Bordonali, E., Roberts, K.L., Santos, C., Gillim-Ross, L., Scull, M.A., PLoS Pathogens, 2009, 10.1371/journal.ppat.1000424

Safety evaluation in chickens of candidate human vaccines against potential pandemic strains of influenza, Swayne, D., Beck, J., Subbarao, K., Cox, N., Chen, H., Matsuoka, Y., Avian Diseases, 2003

Immunohistochemical and in situ hybridization studies of influenza A virus infection in human lungs, Zaki, S.R., Cox, N., Freifeld, A., Nolte, K.B., Morken, T., Ferebee, T., Shaw, M., Subbarao, K., Dawson, J., Shieh, W.-J., Guarner, J., American Journal of Clinical Pathology, 2000, 10.1309/HV74-N24T-2K2C-3E8Q

Transmission studies resume for avian flu, Webster, R.G., Webby, R.J., Tumpey, T.M., Tripp, R.A., Thomas, P.G., Taubenberger, J.K., Tashiro, M., Takimoto, T., Swayne, D.E., Subbarao, K., Steel, J., Schultz-Cherry, S., Richt, J.A., Perez, D.R., Peiris, J.S.M., Palese, P., Osterhaus, A.D.M.E., Mettenleiter, T.C., Lowen, A., Liu, X., Liu, J., Kobinger, G., Klenk, H.D., Kiselev, O.I., Katz, J.M., Guan, Y., Feldmann, H., Donis, R.O., Doherty, P.C., Cox, N.J., Couch, R.B., Compans, R.W., Chen, H., Capua, I., Brown, I.H., Bouvier, N.M., Barclay, W.S., Kawaoka, Y., García-Sastre, A., Fouchier, R.A.M., Science, 2013, 10.1126/science.1235140

An addition to treatment options for avian influenza A H5N1?, Subbarao, K., Baz, M., The Lancet Infectious Diseases, 2015, 10.1016/S1473-3099(15)70019-8

Mammalian infections with highly pathogenic avian influenza viruses renew concerns of pandemic potential, Kanta Subbarao, Brad Gilbertson, Journal of Experimental Medicine, 2023, 10.1084/jem.20230447

Are there alternative avian influenza viruses for generation of stable attenuated avian-human influenza A reassortant viruses?, Murphy, B.R., Kawaoka, Y., Webster, R.G., Subbarao, K., Virus Research, 1995, 10.1016/0168-1702(95)00082-8

pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN, Nabel, G.J., Subbarao, K., Schwartz, O., Kong, W.-P., Leung, K., Ganesh, L., Huang, Y., Yang, Z.-Y., Journal of Virology, 2004, 10.1128/JVI.78.11.5642-5650.2004

Potent vesicular stomatitis virus-based avian influenza vaccines provide long-term sterilizing immunity against heterologous challenge, Rose, J.K., Subbarao, K., Feldmann, H., Kobinger, G., Kobasa, D., Silaghi, A., Suguitan Jr., A.L., Buonocore, L., Schwartz, J.A., Journal of Virology, 2010, 10.1128/JVI.02637-09

An open label Phase I trial of a live attenuated H6N1 influenza virus vaccine in healthy adults, Subbarao, K., Kemble, G., Coelingh, K.L., Jin, H., Lamirande, E.W., Chen, G.L., McMahon, B.A., Thumar, B., Luke, C.J., Karron, R.A., Talaat, K.R., Vaccine, 2011, 10.1016/j.vaccine.2011.02.043

Molecular correlates of influenza A H5N1 virus pathogenesis in mice, Subbarao, K., Shaw, M.W., Smith, C.B., Tumpey, T.M., Lu, X., Katz, J.M., Journal of Virology, 2000, 10.1128/JVI.74.22.10807-10810.2000

Scientific barriers to developing vaccines against avian influenza viruses, Joseph, T., Subbarao, K., Nature Reviews Immunology, 2007, 10.1038/nri2054

Can immunity induced by the human influenza virus N1 neuraminidase provide some protection from avian influenza H5N1 viruses?, Subbarao, K., Gillim-Ross, L., PLoS Medicine, 2007, 10.1371/journal.pmed.0040091

Refining the approach to vaccines against influenza A viruses with pandemic potential, Subbarao, K., Czako, R., Future Virology, 2015, 10.2217/fvl.15.69

Molecular determinants of severe acute respiratory syndrome coronavirus pathogenesis and virulence in young and aged mouse models of human disease, Baric, R.S., Subbarao, K., Scorpio, D., Woodruff, B., Vogel, L., Roberts, A., Donaldson, E., Page, C., Agnihothram, S., Yount, B., Frieman, M., Journal of Virology, 2012, 10.1128/JVI.05957-11

Human infections with avian influenza viruses., Subbarao, K., Joseph, T., Maryland medicine : MM : a publication of MEDCHI, the Maryland State Medical Society, 2005

African green monkeys recapitulate the clinical experience with replication of live attenuated pandemic influenza virus vaccine candidates, Subbarao, K., Kemble, G., Jin, H., Marino, M., Feldmann, H., Feldmann, F., Gardner, D.J., Boonnak, K., Paskel, M., Orandle, M., Suguitan Jr., A., Matsuoka, Y., Journal of Virology, 2014, 10.1128/JVI.00425-14

Molecular aspects of avian influenza (H5N1) viruses isolated from humans, Shaw, M.W., Subbarao, K., Reviews in Medical Virology, 2000, 10.1002/1099-1654(200009/10)10:5<337::AID-RMV292>3.0.CO;2-V

Evaluation of the attenuation, immunogenicity, and efficacy of a live virus vaccine generated by codon-pair bias de-optimization of the 2009 pandemic H1N1 influenza virus, in ferrets, Subbarao, K., Mueller, S., Wimmer, E., Anafu, A., Santos, C.P., Broadbent, A.J., Vaccine, 2016, 10.1016/j.vaccine.2015.11.054

A live attenuated equine H3N8 influenza vaccine is highly immunogenic and efficacious in mice and ferrets, Subbarao, K., Jin, H., Treanor, J.J., Cheng, X., Zengel, J., Matsuoka, Y., Paskel, M., Baz, M., Journal of Virology, 2015, 10.1128/JVI.02449-14

Evaluation of replication and pathogenicity of avian influenza A H7 subtype viruses in a mouse model, Subbarao, K., Kemble, G., Jin, H., Lu, B., McAuliffe, J., Joseph, T., Journal of Virology, 2007, 10.1128/JVI.00970-07

SARS CoV subunit vaccine: Antibodymediated neutralisation and enhancement, Altmeyer, R., Nal, B., Peiris, J.S.M., Subbarao, K., Bruzzone, R., Daeron, M., Escriou, N., Dutry, I., Li, P.H., Roberts, A., Kien, F., Cheung, C.Y., Kam, Y.W., Yip, M.S., Jaume, M., Hong Kong Medical Journal, 2012

A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice., Subbarao, K., Baric, R., Zaki, S.R., Genrich, G.L., Heise, M., Sheahan, T., Herman, B.D., Vogel, L., Yount, B., Cheng, A., Paddock, C.D., Deming, D., Roberts, A., PLoS pathogens, 2007, 10.1371/journal.ppat.0030005

What level of neutralising antibody protects from COVID-19?, Miles P Davenport, James A Triccas, Stephen J Kent, Kanta Subbarao, Jennifer A Juno, Adam K Wheatley, Timothy E Schlub, Arnold Reynaldi, Deborah Cromer, David S Khoury, 2021, 10.1101/2021.03.09.21252641

Intercontinental circulation of human influenza A(H1N2) reassortant viruses during the 2001-2002 influenza season, Klimov, A., Cox, N.J., Subbarao, K., Hall, H.E., Lindstrom, S.E., Mungall, B.A., Smith, C.B., Xu, X., Journal of Infectious Diseases, 2002, 10.1086/344738

Global epidemiology of influenza: Past and present, Subbarao, K., Cox, N. J., Annual Review of Medicine, 2000, 10.1146/annurev.med.51.1.407

Palmitylation of the influenza virus hemagglutinin (H3) is not essential for virus assembly or infectivity, Lamb, R.A., Murphy, B.R., Leser, G.P., Bagai, S., Subbarao, K., Jin, H., Journal of Virology, 1996

Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal antibodies reveals potential vaccine and diagnostic targets, Golding, H., Subbarao, K., King, L.R., Manischewitz, J., Sallusto, F., Lanzavecchia, A., Simmons, C.P., Rivera, Y., Suguitan Jr., A.L., Khurana, S., PLoS Medicine, 2009, 10.1371/journal.pmed.1000049

Influenza, Subbarao, K., Cox, N.J., Lancet, 1999, 10.1016/S0140-6736(99)01241-6

Engineering H5N1 avian influenza viruses to study human adaptation, Taubenberger, J.K., Subbarao, K., Morens, D.M., Nature, 2012, 10.1038/nature11170

DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice, Katz, J.M., Sambhara, S., Renshaw, M., Subbarao, K., Cooper, L.A., Lo, C.-Y., Misplon, J.A., Tumpey, T.M., Epstein, S.L., Emerging Infectious Diseases, 2002

Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses, Bryant, M., Hietala, S., Woods, L., Yaying, J., Delia, M., Perdue, M.L., Subbarao, K., Klimov, A., Chongguang, L., Shengqiang, L., Journal of Infectious Diseases, 1999, 10.1086/314713

Genetic characterization of the pathogenic influenza A/Goose/Guangdong/1/96 (H5N1) virus: Similarity of its hemagglutinin gene to those of H5N1 viruses from the 1997 outbreaks in Hong Kong, Guo, Y., Cox, N.J., Subbarao, K., Xu, X., Virology, 1999, 10.1006/viro.1999.9820

Toxicological evaluation of live attenuated, cold-adapted H5N1 vaccines in ferrets, Coelingh, K.L., Kemble, G., Murphy, B., Subbarao, K., Luke, C., Leininger, J., Manetz, S., Jin, H., Vaccine, 2007, 10.1016/j.vaccine.2007.10.032

Comparison of a live attenuated 2009 H1N1 vaccine with seasonal influenza vaccines against 2009 pandemic H1N1 virus infection in mice and ferrets, Subbarao, K., Kemble, G., Jin, H., Santos, C., Lamirande, E.W., Min, J.-Y., Chen, G.L., Journal of Infectious Diseases, 2011, 10.1093/infdis/jiq144

Generation and Protective Ability of Influenza Virus-Specific Antibody-Dependent Cellular Cytotoxicity in Humans Elicited by Vaccination, Natural Infection, and Experimental Challenge, Subbarao, K., Rosenberger, C.M., Treanor, J., Wright, P.F., Yewdell, J.W., McBride, J.M., Wieland-Alter, W.F., Sangster, M.Y., Hickman, H.D., Luke, C., Jegaskanda, S., Journal of Infectious Diseases, 2016, 10.1093/infdis/jiw262

Evaluation of replication and cross-reactive antibody responses of H2 subtype influenza viruses in mice and ferrets, Subbarao, K., Kemble, G., Jin, H., Yang, C.-F., Lamirande, E.W., Chen, G.L., Journal of Virology, 2010, 10.1128/JVI.00511-10

Activation of the innate immune system provides broad-spectrum protection against influenza A viruses with pandemic potential in mice, Subbarao, K., Ooi, E.-E., Tang, L.-H., Lau, Y.-F., Virology, 2010, 10.1016/j.virol.2010.07.008

A severe acute respiratory syndrome coronavirus that lacks the E gene is attenuated in vitro and in vivo, Enjuanes, L., Subbarao, K., Zaki, S.R., Shieh, W.-J., Roberts, A., Lamirande, E., Rejas, M.T., Almazán, F., Álvarez, E., DeDiego, M.L., Journal of Virology, 2007, 10.1128/JVI.01467-06

Eurasian-origin gene segments contribute to the transmissibility, aerosol release, and morphology of the 2009 pandemic H1N1 influenza virus, Subbarao, K., Jin, H., Lindsley, W.G., Matsuoka, Y., Vogel, L., Santos, C.P., Wang, W., Suguitan, A.L., Lamirande, E.W., Lakdawala, S.S., PLoS Pathogens, 2011, 10.1371/journal.ppat.1002443

Avian-to-human transmission of H9N2 subtype influenza A viruses: Relationship between H9N2 and H5N1 human isolates, Hay, A., Cox, N., Webster, R., Shortridge, K., Krauss, S., Guan, Y., Subbarao, K., Klimov, A., Lim, W., Cameron, K., Gregory, V., Shaw, M., Lin, Y.P., Proceedings of the National Academy of Sciences of the United States of America, 2000

Boosted influenza-specific T cell responses after H5N1 pandemic live attenuated influenza virus vaccination, Dong, T., Subbarao, K., McMichael, A., Dong, D., Luke, C.J., Zeng, H., Powell, T.J., Karron, R., Talaat, K., Wang, B., Peng, Y., Frontiers in Immunology, 2015, 10.3389/fimmu.2015.00287

Development of a high-yield live attenuated H7N9 influenza virus vaccine that provides protection against homologous and heterologous H7 wild-type viruses in ferrets, Matsuoka, Y., Jin, H., Subbarao, K., Santos, C., Paskel, M., Lu, J., Baz, M., Chen, Z., Journal of Virology, 2014, 10.1128/JVI.00100-14

Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection, Wilson, P.C., Krammer, F., Palese, P., Subbarao, K., Topham, D.J., Treanor, J.J., Terajima, M., Ennis, F.A., Mullarkey, C.E., Zheng, N.-Y., Hirsh, A., Cruz, J., Tan, G.S., Ho, I.Y., Chromikova, V., Choi, A., Huang, M., Leon, P.E., Henry Dunand, C.J., Cell Host and Microbe, 2016, 10.1016/j.chom.2016.05.014

Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV, Taylor, D.R., Feinstone, S.M., Subbarao, K., Darnell, M.E.R., Journal of Virological Methods, 2004, 10.1016/j.jviromet.2004.06.006

Evaluation of the Safety and Immunogenicity of a Candidate Pandemic Live Attenuated Influenza Vaccine (pLAIV) Against Influenza A(H7N9), Subbarao, K., Treanor, J., Luke, C., Chen, Z., Mallory, R., Fitzgerald, T., Jegaskanda, S., Matsuoka, Y., Sobhanie, M., Journal of Infectious Diseases, 2016, 10.1093/infdis/jiv526

Respiratory syncytial virus-specific immunoglobulins in preterm infants, Subbarao, E.K., Murphy, B.R., Wasser, T.E., Kumar, M.L., de Sierra, T.M., The Journal of Pediatrics, 1993, 10.1016/S0022-3476(06)80027-2

Polygenic virulence factors involved in pathogenesis of 1997 Hong Kong H5N1 influenza viruses in mice, Matsuoka, Y., Katz, J.M., Cox, N.J., Smith, C., Subbarao, K., Bright, R.A., Chen, H., Virus Research, 2007, 10.1016/j.virusres.2007.04.017

The Pandemic Threat of Avian Influenza Viruses, Subbarao, K., Suguitan Jr., A.L., Perspectives in Medical Virology, 2006, 10.1016/S0168-7069(06)16005-X

Influenza Viruses, Fiore, A.E., Subbarao, K., Dawood, F.S., Principles and Practice of Pediatric Infectious Diseases: Fourth Edition, 2012, 10.1016/B978-1-4377-2702-9.00231-2

Vaccines for pandemic influenza, Subbarao, K., Luke, C.J., Emerging Infectious Diseases, 2006

Immunogenicity of prime-boost protein subunit vaccine strategies against SARS-CoV-2 in mice and macaques, Adam K. Wheatley, Stephen J. Kent, Kanta Subbarao, Francesca L. Mordant, Thakshila Amarasena, Robyn Esterbauer, Kathleen M. Wragg, Hannah G. Kelly, Isaac Barber-Axthelm, Wen Shi Lee, Jennifer A. Juno, Hyon-Xhi Tan, Nature Communications, 2021, 10.1038/s41467-021-21665-8

Nonreplicating influenza a virus vaccines confer broad protection against lethal challenge, Subbarao, K., Townsend, A., Powell, T., Santos, C., Paskel, M., Boonnak, K., Baz, M., mBio, 2015, 10.1128/mBio.01487-15

Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets, Subbarao, K., Kemble, G., Swayne, D.E., Murphy, B., Luke, C.J., Lu, B., Duke, G., Jin, H., Mills, K.L., McAuliffe, J., Suguitan Jr., A.L., PLoS Medicine, 2006, 10.1371/journal.pmed.0030360

Genetic characterization of H3N2 influenza viruses isolated from pigs in North America, 1977-1999: Evidence for wholly human and reassortant virus genotypes, Olsen, C.W., Carman, S., Anderson, G.A., Subbarao, K., Smith, C.B., Cooper, L.A., Schutten, M.M., Karasin, A.I., Virus Research, 2000, 10.1016/S0168-1702(00)00154-4

Contributions of the structural proteins of severe respiratory syndrome coronavirus to protective immunity, Collins, P.L., Subbarao, K., Murphy, B.R., Lamirande, E.W., Yang, L., Bukreyev, A., Buchholz, U.J., Proceedings of the National Academy of Sciences of the United States of America, 2004, 10.1073/pnas.0403492101

Advances in Influenza Virus Research: A Personal Perspective, Kanta Subbarao, Viruses, 2018, 10.3390/v10120724

Role of the viral polymerase during adaptation of influenza A viruses to new hosts, Kanta Subbarao, Melanie Duncan, Brad Gilbertson, Current Opinion in Virology, 2023, 10.1016/j.coviro.2023.101363

Reappearance and global spread of variants of influenza B/Victoria/2/87 lineage viruses in the 2000-2001 and 2001-2002 seasons, Subbarao, K., Cox, N.J., Klimov, A., Hall, H., Kunimoto, G.Y., Ueki, R.T., Normand, S., Li, Y., Xu, X., Shaw, M.W., Virology, 2002, 10.1006/viro.2002.1719

Rapid detection of respiratory syncytial virus by a biotin–enhanced immunoassay: Test performance by laboratory technologists and housestaff, Kumar, M.L., Thomas, F., Super, D.M., Black, C.J., De Sierra, T.M., Dietrich, M.C., Subbarao, E.K., Pediatric Infectious Disease Journal, 1989

Immune Responses to Avian Influenza Viruses, Kanta Subbarao, Katherine Kedzierska, Marios Koutsakos, The Journal of Immunology, 2019, 10.4049/jimmunol.1801070

Neuraminidase stalk length and additional glycosylation of the hemagglutinin influence the virulence of influenza H5N1 viruses for mice, Subbarao, K., Donis, R., Altholtz, M., Warnes, C., Naffakh, N., Rameix-Welti, M.-A., Thomas, C., Swayne, D.E., Matsuoka, Y., Journal of Virology, 2009, 10.1128/JVI.01987-08

Correction to "Severity of clinical disease and pathology in ferrets experimentally infected with influenza viruses is influenced by inoculum volume" [J Virol., 88, 23, (2014), 13879-13891], Subbarao, K., Qin, J., Kenney, H., Donahue, D., Paskel, M., Lamirande, E.W., Moore, I.N., Journal of Virology, 2016, 10.1128/JVI.02806-15

Predicting the evolution of human influenza A, Cox, N.J., Subbarao, K., Bender, C.A., Bush, R.M., Fitch, W.M., Journal of Heredity, 2000

Influenza A virus infection complicated by fatal myocarditis, Zaki, S.R., Cox, N.J., Morken, T., Dawson, J.E., Shieh, W.-J., Guarner, J., Subbarao, K., Shaw, M.W., Oty, G., Alakija, P., Nolte, K.B., American Journal of Forensic Medicine and Pathology, 2000, 10.1097/00000433-200012000-00016

Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses, McDermott, A.B., Mascola, J.R., Kwong, P.D., Shapiro, L., Roederer, M., Ledgerwood, J.E., Koup, R.A., Graham, B.S., Douek, D.C., Subbarao, K., Mullikin, J.C., Baxa, U., Tsybovsky, Y., Matsuoka, Y., Santos, C., Yassine, H.M., Wu, X., Whittle, J.R., Wang, L., Shen, C.-H., Ransier, A., Lees, C.R., Darko, S., Bylund, T., Boyington, J.C., Asokan, M., Zhang, Y., Zhang, B., Yang, E.S., Prabhakaran, M.S., Narpala, S.N., Leung, K., Kong, W.-P., Kanekiyo, M., Gillespie, R.A., Georgiev, I.S., Druz, A., Bailer, R.T., Soto, C., Chuang, G.-Y., Thomas, P.V., Wheatley, A.K., Joyce, M.G., Cell, 2016, 10.1016/j.cell.2016.06.043

Safety, immunogencity, and efficacy of a cold-adapted A/Ann Arbor/6/60 (H2N2) vaccine in mice and ferrets, Subbarao, K., Kemble, G., Jin, H., Lamirande, E.W., Chen, G.L., Virology, 2010, 10.1016/j.virol.2009.12.003

Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice, Moss, B., Subbarao, K., Murphy, B.R., Collins, P.L., Bukreyev, A., Vogel, L., Roberts, A., Bisht, H., Proceedings of the National Academy of Sciences of the United States of America, 2004, 10.1073/pnas.0401939101

Convalescent plasma treatment for COVID‐19: Tempering expectations with the influenza experience, Rajeev Rudraraju, Francesca Mordant, Kanta Subbarao, European Journal of Immunology, 2020, 10.1002/eji.202048723

Structure and accessibility of HA trimers on intact 2009 H1N1 pandemic influenza virus to stem region-specific neutralizing antibodies, Subramaniam, S., Subbarao, K., Sapiro, G., Yewdell, J.W., Das, S.R., Bliss, D., Moran, A., Kuybeda, O., Matsuoka, Y., Meyerson, J.R., Harris, A.K., Proceedings of the National Academy of Sciences of the United States of America, 2013, 10.1073/pnas.1214913110

Emerging respiratory viruses: Challenges and vaccine strategies, Subbarao, K., Gillim-Ross, L., Clinical Microbiology Reviews, 2006, 10.1128/CMR.00005-06

The prospects and challenges of universal vaccines for influenza, Matsuoka, Y., Subbarao, K., Trends in Microbiology, 2013, 10.1016/j.tim.2013.04.003

FDA/NIH/WHO public workshop on immune correlates of protection against influenza A viruses in support of pandemic vaccine development, Bethesda, Maryland, US, December 10-11, 2007, Wood, D., Friede, M., Luke, C.J., Subbarao, K., Weir, J., Hess, M., Golding, H., Eichelberger, M., Vaccine, 2008, 10.1016/j.vaccine.2008.06.012

Generation and characterization of a cold-adapted influenza A H9N2 reassortant as a live pandemic influenza virus vaccine candidate, Subbarao, K., Murphy, B.R., Cox, N.J., Chen, Q., Swayne, D., Matsuoka, Y., Chen, H., Vaccine, 2003, 10.1016/S0264-410X(03)00430-4

Lack of transmission of H5N1 avian-human reassortant influenza viruses in a ferret model, Katz, J.M., Subbarao, K., Cox, N.J., Donis, R.O., Tumpey, T.M., Harun, S., Sedyaningsih, E.R., Mai, L.Q., Hien, N.T., Falćon, A., Ortin, J., Rowe, T., Chen, H., Matsuoka, Y., Chen, L.-M., Maines, T.R., Proceedings of the National Academy of Sciences of the United States of America, 2006, 10.1073/pnas.0605134103

Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults, Subbarao, K., Kemble, G., Murphy, B.R., Jin, H., Coelingh, K., Lamirande, E., Chen, G., Mills, K., Suguitan, A., Schappell, E., McAuliffe, J., DiLorenzo, S., Thumar, B., Callahan, K., Luke, C., Talaat, K., Karron, R.A., Vaccine, 2009, 10.1016/j.vaccine.2009.05.099

Live attenuated vaccines for pandemic influenza, Subbarao, K., Chen, G.L., Current Topics in Microbiology and Immunology, 2009, 10.1007/978-3-540-92165-3-5

Sequential Transmission of Influenza Viruses in Ferrets Does Not Enhance Infectivity and Does Not Predict Transmissibility in Humans, Kanta Subbarao, Sebastian Maurer-Stroh, Raphael T. C. Lee, Elodie Ghedin, Rita Czako, Katherine E. E. Johnson, Devanshi R. Patel, Elaine W. Lamirande, Troy C. Sutton, mBio, 2022, 10.1128/mbio.02540-22

H5N1 viruses and vaccines, Luke, C., Subbarao, K., PLoS Pathogens, 2007, 10.1371/journal.ppat.0030040

The open reading frame 3a protein of severe acute respiratory syndrome-associated coronavirus promotes membrane rearrangement and cell death, Lenardo, M.J., Subbarao, K., Baric, R.S., Xu, X.-N., Zaki, S.R., Lippincott-Schwartz, J., Screaton, G.R., Buchholz, U.J., Frieman, M.B., Liu, W., Yount, B., Cheng, A., Welsh, S., Goldsmith, C.S., Yu, L., Freundt, E.C., Journal of Virology, 2010, 10.1128/JVI.01662-09

Molecular changes associated with the transmission of avian influenza A H5N1 and H9N2 viruses to humans, Subbarao, K., Shortridge, K., Lim, W., Webster, R., Cox, N., Klimov, A., Zhou, N., Guan, Y., Krauss, S., Thompson, W., Xu, X., Cooper, L., Shaw, M., Journal of Medical Virology, 2002, 10.1002/jmv.2118

Comparative Longitudinal Serological Study of Anti-SARS-CoV-2 Antibody Profiles in People with COVID-19, Hans Juergen Netter, Julian Druce, Leon Caly, Kanta Subbarao, Mike Catton, Francesca Mordant, Pamela Konecny, Andrew Lloyd, Nicole Gilroy, Bernard Hudson, Jeffrey J. Post, Michael MIna, William Rawlinson, Marianne Martinello, Rowena Bull, Suellen Nicholson, Marilou H. Barrios, Microorganisms, 2023, 10.3390/microorganisms11081985

Vaccination with DNA encoding internal proteins of influenza virus does not require CD8⁺ cytotoxic T lymphocytes: Either CD4⁺ or CD8⁺ T cells can promote survival and recovery after challenge, Subbarao, K., Bennink, J., Mostowski, H., Lo, C.-Y., Misplon, J.A., Stack, A., Epstein, S.L., International Immunology, 2000

The 2009 pandemic H1N1 virus induces anti-neuraminidase (NA) antibodies that cross-react with the NA of H5N1 viruses in ferrets, Jin, H., Subbarao, K., Kim, L., Chen, Z., Vaccine, 2012, 10.1016/j.vaccine.2012.01.090

A single dose of an avian H3N8 influenza virus vaccine is highly immunogenic and efficacious against a recently emerged seal influenza virus in mice and ferrets, Subbarao, K., Jin, H., Treanor, J.J., Cheng, X., Zengel, J.R., Matsuoka, Y., Paskel, M., Baz, M., Journal of Virology, 2015, 10.1128/JVI.00280-15

Comparative study of influenza virus epithelium cells derived from adenoids and airway replication in MDCK cells and in primary, Wright, P.F., Subbarao, K., Treanor, J.J., Rudenko, L.G., Kawaoka, Y., Ikizler, M.R., Ilyushina, N.A., Journal of Virology, 2012, 10.1128/JVI.01477-12

Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection (The Journal of Experimental Medicine (2011) 208, 1, (181-193)), Wilson, P.C., Ahmed, R., Compans, R., Mulligan, M.J., Marasco, W.A., Subbarao, K., Yewdell, J.W., O'Donnell, C.D., Das, S.R., Wang, Y., Amara, R.R., Andrews, S., Kaur, K., Ali, Z., Huang, M., Lee, J.-H., Zheng, N.-Y., Del Rio, C., Razavi, B., Mehta, A., Lipkin, W.I., Hornig, M., Skountzou, I., McCausland, M., Morrissey, M., Sui, J., Edupuganti, S., Li, G.-M., Koutsonanos, D., Wrammert, J., Journal of Experimental Medicine, 2011, 10.1084/jem.201013522082c

Antigen-activated dendritic cells ameliorate influenza A infections, Subbarao, K., Talor, E., Zimmerman, D., Orandle, M., Vogel, L., Boonnak, K., Journal of Clinical Investigation, 2013, 10.1172/JCI67550

Lymphopenia associated with highly virulent H5N1 virus infection due to plasmacytoid dendritic cell-mediated apoptosis of T cells, Subbarao, K., Legge, K.L., Feldmann, H., Feldmann, F., Boonnak, K., Vogel, L., Journal of Immunology, 2014, 10.4049/jimmunol.1302992

A live attenuated cold-adapted influenza A H7N3 virus vaccine provides protection against homologous and heterologous H7 viruses in mice and ferrets, Subbarao, K., Kemble, G., Jin, H., Swayne, D., Vogel, L., Lu, B., McAuliffe, J., Joseph, T., Virology, 2008, 10.1016/j.virol.2008.05.021

Generation and evaluation of a high-growth reassortant H9N2 influenza A virus as a pandemic vaccine candidate, Matsuoka, Y., Cox, N., Katz, J., Lu, X., Chen, Q., Swayne, D., Subbarao, K., Chen, H., Vaccine, 2003, 10.1016/S0264-410X(02)00809-5

A single dose of any of four different live attenuated tetravalent dengue vaccines is safe and immunogenic in flavivirus-naive adults: A randomized, double-blind clinical trial, Whitehead, S.S., Subbarao, K., Murphy, B.R., Luke, C.J., Carmolli, M.P., Wanionek, K., Hynes, N.A., Talaat, K.R., Shaffer, D., Sabundayo, B.P., Tibery, C., Lindow, J.C., Larsson, C.J., Elwood, D., Pierce, K.K., Kirkpatrick, B.D., Durbin, A.P., Journal of Infectious Diseases, 2013, 10.1093/infdis/jis936

Animal models for SARS., Subbarao, K., Roberts, A., Advances in experimental medicine and biology, 2006

Influenza vaccines: present and future., Subbarao, K., Advances in virus research, 1999

Sequential addition of temperature-sensitive missense mutations into the PB2 gene of influenza a transfectant viruses can effect an increase in temperature sensitivity and attenuation and permits the rational design of a genetically engineered live influenza A virus vaccine, Murphy, B.R., Chen, A.Y., Lawson, C.M., Park, E.J., Subbarao, E.K., Journal of Virology, 1995

SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism, Baric, R.S., Subbarao, K., Heise, M., Roberts, A., Lamirande, E.W., Ward, J.M., Funkhouser, W., Whitmore, A., Morrison, T.E., Chen, J., Frieman, M.B., PLoS Pathogens, 2010

Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB/c mice: CD4⁺ T Cells are important in control of SARS-CoV infection, Subbarao, K., Zaki, S.R., Bartlett, J.H., Paddock, C.D., Lamirande, E.W., Lau, Y.F., Chen, J., Journal of Virology, 2010, 10.1128/JVI.01281-09

Opposing Effects of Prior Infection versus Prior Vaccination on Vaccine Immunogenicity against Influenza A(H3N2) Viruses, Sheena G. Sullivan, H. Rogier van Doorn, Le Thi Quynh Mai, Kanta Subbarao, Ian Barr, Pham Quang Thai, Yeu-Yang Tseng, Maria Auladell, Arseniy Khvorov, Hoang Vu Mai Phuong, Vivian Leung, Louise Carolan, Annette Fox, Viruses, 2022, 10.3390/v14030470

Replication and immunogenicity of swine, equine, and avian H3 subtype influenza viruses in mice and ferrets, Subbaraoa, K., Jin, H., Cheng, X., Zengel, J., Matsuoka, Y., Paskel, M., Baz, M., Journal of Virology, 2013, 10.1128/JVI.03520-12

Vaccines, Subbarao, K., Severe Acute Respiratory Syndrome, 2008, 10.1002/9780470755952.ch21

Live attenuated H7N7 influenza vaccine primes for a vigorous antibody response to inactivated H7N7 influenza vaccine, Subbarao, K., Treanor, J., Katz, J., Topham, D., Jin, H., Sangster, M.Y., Luke, C., Fitzgerald, T., Levine, M., Babu, T.M., Vaccine, 2014, 10.1016/j.vaccine.2014.09.070

Generation and characterization of an H9N2 cold-adapted reassortant as a vaccine candidate, Subbarao, K., Murphy, B.R., Cox, N.J., Chen, Q., Matsuoka, Y., Chen, H., Avian Diseases, 2003

A live attenuated influenza A(H5N1) vaccine induces long-term immunity in the absence of a primary antibody response, Subbarao, K., Neuzil, K.M., Golding, H., Follmann, D.A., Qin, J., Lewis, K.D.C., Karron, R.A., McMahon, B.A., King, L.R., Manischewitz, J., Khurana, S., Luke, C.J., Talaat, K.R., Journal of Infectious Diseases, 2014, 10.1093/infdis/jiu123

The immunobiology of SARS, Subbarao, K., Chen, J., Annual Review of Immunology, 2007, 10.1146/annurev.immunol.25.022106.141706

A new route to vaccines using PROTACs, Kanta Subbarao, Brad Gilbertson, Nature Biotechnology, 2022, 10.1038/s41587-022-01406-y

Live Attenuated Influenza Vaccines for Pandemic Preparedness, Kanta Subbarao, Journal of the Pediatric Infectious Diseases Society, 2020, 10.1093/jpids/piz073

Utility of the aged BALB/c mouse model to demonstrate prevention and control strategies for Severe Acute Respiratory Syndrome coronavirus (SARS-CoV), Subbarao, K., Zaki, S.R., Rose, J.K., Kapadia, S.U., Lamirande, E.W., Genrich, G.L., Paddock, C.D., Roberts, A., Vogel, L.N., Vaccine, 2007, 10.1016/j.vaccine.2006.11.055

The Critical Interspecies Transmission Barrier at the Animal–Human Interface, Kanta Subbarao, Tropical Medicine and Infectious Disease, 2019, 10.3390/tropicalmed4020072

An adjuvant for the induction of potent, protective humoral responses to an H5N1 influenza virus vaccine with antigen-sparing effect in mice, Subbarao, K., Ooi, E.-E., McCall, A.W., Tang, L.-H., Lau, Y.-F., Journal of Virology, 2010, 10.1128/JVI.00596-10

Rescue of an influenza A virus wild-type PB2 gene and a mutant derivative bearing a site-specific temperature-sensitive and attenuating mutation, Murphy, B.R., Kawaoka, Y., Subbarao, E.K., Journal of Virology, 1993

Comparison of two enzyme-linked immunosorbent assay (EIA) kits with immunofluorescence and isolation in cell culture for detection of respiratory syncytial virus (RSV), Waner, J.L., Whitehurst, N.J., Subbarao, E.K., Diagnostic Microbiology and Infectious Disease, 1987, 10.1016/0732-8893(87)90054-X

Molecular epidemiology of influenza A(H3N2) virus reinfections, Glezen, W.P., Taber, L.H., Subbarao, K., Cox, N.J., Smith, C.B., Journal of Infectious Diseases, 2002, 10.1086/339416

Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza, Subbarao, K., Lanzavecchia, A., De Jong, M.D., Farrar, J., Do, Q.H., Sallusto, F., Tran, T.H., Chau, N.V.V., Ward, J.M., Mills, K., Suguitan Jr., A.L., Bernasconi, N.L., Simmons, C.P., PLoS Medicine, 2007, 10.1371/journal.pmed.0040178

Structures of complexes formed by H5 influenza hemagglutinin with a potent broadly neutralizing human monoclonal antibody, Skehel, J.J., Gamblin, S.J., Lanzavecchia, A., Subbarao, K., Temperton, N.J., Santos, C., Suguitan, A.L., Monne, I., Collins, P.J., Walker, P.A., Lin, Y.P., Martin, S.R., Calder, L.J., Foglierini, M., Pinna, D., Liu, J., Corti, D., Xiong, X., Proceedings of the National Academy of Sciences of the United States of America, 2015, 10.1073/pnas.1510816112

An efficient method to make human monoclonal antibodies from memory B cells: Potent neutralization of SARS coronavirus, Lanzavecchia, A., Rappuoli, R., Murphy, B.R., Gismondo, M.R., Uematsu, Y., Kolesnikova, L., Subbarao, K., Becker, S., Traggiai, E., Nature Medicine, 2004, 10.1038/nm1080

Extending the Breadth of Influenza Vaccines: Status and Prospects for a Universal Vaccine, Kanta Subbarao, Kylie M. Quinn, Annette Fox, Drugs, 2018, 10.1007/s40265-018-0958-7

Animal models for sars, Subbarao, K., Roberts, A., Advances in Experimental Medicine and Biology, 2006, 10.1007/978-0-387-33012-9_83

The challenge of flu transmission, Subbarao, K., Lakdawala, S.S., Nature Medicine, 2012, 10.1038/nm.2953

Development and characterization of a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice, Ambrosino, D.M., Sullivan, J.L., Luzuriaga, K., Somasundaran, M., Vogel, L., Subbarao, K., Finberg, R.W., Lowy, I., Srinivasan, M., Graziano, R.F., Coccia, J.A., Thomas Jr., W.D., Hernandez, H.J., Roberts, A., Babcock, G.J., Greenough, T.C., Journal of Infectious Diseases, 2005, 10.1086/427242

The PB2 subunit of the influenza virus RNA polymerase affects virulence by interacting with the mitochondrial antiviral signaling protein and inhibiting expression of beta interferon, Fodor, E., Subbarao, K., Carr, S.M., McCall, A.W., Lau, Y.-F., Vreede, F.T., Graef, K.M., Journal of Virology, 2010, 10.1128/JVI.00879-10

Development of effective vaccines against pandemic influenza, Fauci, A.S., Murphy, B.R., Subbarao, K., Immunity, 2006, 10.1016/j.immuni.2005.12.005

Vesicular stomatitis virus vectors expressing avian influenza H5 HA induce cross-neutralizing antibodies and long-term protection, Rose, J.K., Subbarao, K., Feldmann, H., Kobinger, G., Kobasa, D., Suguitan Jr., A., Roberts, A., Buonocore, L., Schwartz, J.A., Virology, 2007, 10.1016/j.virol.2007.04.021

Respiratory Virus Vaccines, Subbarao, K., Boonnak, K., Broadbent, A.J., Mucosal Immunology: Fourth Edition, 2015, 10.1016/B978-0-12-415847-4.00059-8

The matrix gene segment destabilizes the acid and thermal stability of the hemagglutinin of pandemic live attenuated influenza virus vaccines, Subbarao, K., Jin, H., Matsuoka, Y., Vogel, L., O'Donnell, C.D., Journal of Virology, 2014, 10.1128/JVI.01107-14

Avian influenza H6 viruses productively infect and cause illness in mice and ferrets, Subbarao, K., Kemble, G., Jin, H., Ye, D., Yang, C.-F., Aspelund, A., Chen, Z., Santos, C., Gillim-Ross, L., Journal of Virology, 2008, 10.1128/JVI.01206-08

Implications of the apparent extinction of B/Yamagata-lineage human influenza viruses, Kanta Subbarao, Ian G. Barr, npj Vaccines, 2024, 10.1038/s41541-024-01010-y

Replication of live attenuated cold-adapted H2N2 influenza virus vaccine candidates in non human primates, Subbarao, K., Jin, H., Chen, Z., Lu, J., Matsuoka, Y., Paskel, M., Santos, C.P., Broadbent, A.J., Vaccine, 2015, 10.1016/j.vaccine.2014.10.065

Influenza vaccines generated by reverse genetics, Katz, J.M., Subbarao, K., Current Topics in Microbiology and Immunology, 2004

Live attenuated influenza vaccine, Subbarao, K., Jin, H., Current Topics in Microbiology and Immunology, 2015

H5N1 vaccine-specific B cell responses in ferrets primed with live attenuated seasonal influenza vaccines, Jin, H., Kemble, G., Subbarao, K., Kulkarni, D., Zhou, H., Xu, Q., Eisenbraun, M., Cheng, X., PLoS ONE, 2009, 10.1371/journal.pone.0004436

Roadblocks to translational challenges on viral pathogenesis, Suzich, J., Subbarao, K., Picker, L., Drosten, C., Deeks, S., Nature Medicine, 2013, 10.1038/nm.3050

A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults, Subbarao, K., Kemble, G., Murphy, B.R., Coelingh, K.L., Jin, H., Lamirande, E.W., Chen, G.L., DiLorenzo, S.C., Luke, C.J., Callahan, K.A., Karron, R.A., Talaat, K.R., Vaccine, 2009, 10.1016/j.vaccine.2009.03.082

An influenza A virus containing influenza B virus 5′ and 3′ noncoding regions on the neuraminidase gene is attenuated in mice, Palese, P., Murphy, B.R., Enami, M., Subbarao, E.K., Muster, T., Proceedings of the National Academy of Sciences of the United States of America, 1991

Avian influenza viruses infecting humans, Katz, J., Subbarao, K., Cellular and Molecular Life Sciences, 2000

Correlates of immunity to influenza as determined by challenge of children with live, attenuated influenza vaccine, Treanor, J.J., Subbarao, K., Luke, C.J., Haynes, B.C., Rosenberg-Hasson, Y., Jegaskanda, S., Connor, R.I., Wieland-Alter, W., Ackerman, M.E., Brown, E.P., Ilyushina, N.A., Hoen, A.G., Wright, P.F., Open Forum Infectious Diseases, 2016, 10.1093/ofid/ofw108

Cellular targets for influenza drugs, Subbarao, K., Min, J.-Y., Nature Biotechnology, 2010, 10.1038/nbt0310-239

H5N1 vaccines in humans, Subbarao, K., Jin, H., Cheng, X., Luke, C.J., Baz, M., Virus Research, 2013, 10.1016/j.virusres.2013.05.006

Moving on Out: Transport and Packaging of Influenza Viral RNA into Virions, Subbarao, K., Fodor, E., Lakdawala, S.S., Annual Review of Virology, 2016, 10.1146/annurev-virology-110615-042345

As good as the real thing, Subbarao, K., Journal of Pediatrics, 2000

Severe acute respiratory syndrome coronavirus infection of Golden Syrian hamsters, Subbarao, K., Zaki, S., Murphy, B., Hayes, N., Guarner, J., Vogel, L., Roberts, A., Journal of Virology, 2005, 10.1128/JVI.79.1.503-511.2005

Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice, Murphy, P.M., Murphy, B., Subbarao, K., Glass, W.G., Journal of Immunology, 2004

Prevaccination serologic screening for measles in health care workers, Kumar, M.L., Amin, S., Subbarao, E.K., Journal of Infectious Diseases, 1991

Evaluation of three live attenuated H2 pandemic influenza vaccine candidates in mice and ferrets, Subbarao, K., Kemble, G., Jin, H., Orandle, M., Torres-Velez, F., Cheng, X., Lamirande, E.W., Chen, G.L., Journal of Virology, 2014, 10.1128/JVI.01829-13

High-affinity H7 head and stalk domain-specific antibody responses to an inactivated influenza H7N7 vaccine after priming with live attenuated influenza vaccine, Sangster, M.Y., Topham, D.J., Golding, H., Subbarao, K., Treanor, J.J., Martínez-Sobrido, L., Yang, H., Baker, S.F., Chung, K.Y., Coyle, E.M., Fitzgerald, T., Krammer, F., Khurana, S., Halliley, J.L., Journal of Infectious Diseases, 2015, 10.1093/infdis/jiv210

SARS vaccine protective in mice [2], Subbarao, K., Abrignani, S., Rappuoli, R., Murphy, B., Klenk, H.-D., Kolesnikova, L., Eickmann, M., Vogel, L., Becker, S., Roberts, A., Stadler, K., Emerging Infectious Diseases, 2005

The role of animal models in influenza vaccine research, Subbarao, K., Luke, C.J., Birkhauser Advances in Infectious Diseases, 2011, 10.1007/978-3-0346-0279-2_10

A simple restriction fragment length polymorphism-based strategy that can distinguish the internal genes of human H1N1, H3N2, and H5N1 influenza a viruses, Subbarao, K., Cooper, L.A., Journal of Clinical Microbiology, 2000

Protective efficacy of influenza group 2 hemagglutinin stem-fragment immunogen vaccines, Kanta Subbarao, Raghavan Varadarajan, Ian N. Moore, Kevin W. Bock, Ketaki Ganti, Elaine W. Lamirande, Vamsee V. A. Mallajosyula, Saborni Chakraborty, Troy C. Sutton, npj Vaccines, 2017, 10.1038/s41541-017-0036-2

Development of animal models against emerging coronaviruses: From SARS to MERS coronavirus, Subbarao, K., Sutton, T.C., Virology, 2015, 10.1016/j.virol.2015.02.030

Postexposure prophylaxis for measles in a neonatal intensive care unit, Kumar, M.L., Greenberg, J., Amin, S., Andrews-Mann, L., Subbarao, E.K., The Journal of Pediatrics, 1990, 10.1016/S0022-3476(05)83344-X

The soft palate is an important site of adaptation for transmissible influenza viruses, Subbarao, K., Sasisekharan, R., Wentworth, D.E., Das, S.R., Orandle, M., Moore, I., Minai, M., Paskel, M., Vogel, L., Hanson, C.T., Simenauer, A., Lin, X., Stockwell, T.B., Shih, A.R., Lamirande, E.W., Halpin, R.A., Jayaraman, A., Lakdawala, S.S., Nature, 2015, 10.1038/nature15379

An open-label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults, Subbarao, K., Kemble, G.W., Coelingh, K.L., Jin, H., Lamirande, E.W., Min, J.-Y., Chen, G.L., Thumar, B., Luke, C.J., Mcmahon, B.A., Liang, P.H., Karron, R.A., Talaat, K.R., Influenza and other Respiratory Viruses, 2013, 10.1111/j.1750-2659.2012.00350.x

The magnitude of local immunity in the lungs of mice induced by live attenuated influenza vaccines is determined by local viral replication and induction of cytokines, Subbarao, K., Torres-Vélez, F.J., Santos, C., Lau, Y.-F., Journal of Virology, 2011, 10.1128/JVI.01564-10

Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies, Dimitrov, D.S., Jiang, S., Subbarao, K., Nabel, G.J., Curtis, K.M., Lanzavecchia, A., Baric, R., Wang, L.-F., Kim, J.-O., Feng, Y., Vogel, L., Corti, O., Sidorov, I.A., Rockx, B., Prabakaran, P., Hensley, L.E., Xiao, D., Sheahan, T., Roberts, A., He, Y., Chakraborti, S., Zhu, Z., Proceedings of the National Academy of Sciences of the United States of America, 2007, 10.1073/pnas.0701000104

Evaluation of candidate vaccine approaches for MERS-CoV, Graham, B.S., Kong, W.-P., Mascola, J.R., Kwong, P.D., Subbarao, K., Rao, S.S., Denison, M.R., Jahrling, P., Hensley, L., Mollura, D.J., Solomon, J., Bagci, U., Todd, J.P., Olinger, G., Johnson, J.C., Vogel, L., Freeman, M., Becker, M.M., Chen, X., Yang, Z.-Y., Kanekiyo, M., Yassine, H.M., Zhou, T., Lees, C.R., Leung, K., Zhang, Y., Modjarrad, K., Joyce, M.G., Shi, W., Wang, L., Nature Communications, 2015, 10.1038/ncomms8712

Correlates of protection, thresholds of protection, and immunobridging in SARS-CoV-2 infection, Miles P Davenport, Stephen J Kent, James A Triccas, Kanta Subbarao, Peter B Gilbert, Youyi Fong, Megan Steain, Deborah Cromer, Timothy E Schlub, David S Khoury, 2022, 10.1101/2022.06.05.22275943

Evaluation of human monoclonal antibody 80R for immunoprophylaxis of severe acute respiratory syndrome by an animal study, epitope mapping, and analysis of spike variants, Marasco, W.A., Farzan, M., Subbarao, K., Wong, S.K., Vogel, L., Murakami, A., Matthews, L.J., Roberts, A., Li, W., Sui, J., Journal of Virology, 2005, 10.1128/JVI.79.10.5900-5906.2005

Pause on avian flu transmission research, Webster, R.G., Webby, R.J., Tumpey, T.M., Tripp, R.A., Thomas, P.G., Taubenberger, J.K., Tashiro, M., Takimoto, T., Swayne, D.E., Subbarao, K., Steel, J., Schultz-Cherry, S., Richt, J.A., Perez, D.R., Peiris, J.S.M., Palese, P., Osterhaus, A.D.M.E., Mettenleiter, T.C., Lowen, A., Liu, X., Liu, J., Kobinger, G., Klenk, H.D., Katz, J., Guan, Y., Feldmann, H., Donis, R.O., Doherty, P.C., Cox, N.J., Couch, R.B., Compans, R.W., Chen, H., Capua, I., Brown, I.H., Bouvier, N.M., Barclay, W.S., Kawaoka, Y., García-Sastre, A., Fouchier, R.A.M., Science, 2012, 10.1126/science.1219412

What influenza activity can we anticipate in 2022?, Kanta Subbarao, Medical Journal of Australia, 2022, 10.5694/mja2.51437

Robust and balanced immune responses to all 4 dengue virus serotypes following administration of a single dose of a live attenuated tetravalent dengue vaccine to healthy, flavivirus-naive adults, Whitehead, S.S., Subbarao, K., Fraser, E.A., Walsh, M.C., Luke, C.J., Lovchik, J.M., Jo, M., Larsson, C.J., Lyon, C.E., Sabundayo, B.P., Jarvis, A.P., Elwood, D., Diehl, S.A., Hynes, N., Grier, P.L., Tibery, C.M., Carmolli, M.P., Pierce, K.K., Durbin, A.P., Kirkpatrick, B.D., Journal of Infectious Diseases, 2015, 10.1093/infdis/jiv082

Live attenuated and inactivated influenza vaccines in children, Wright, P.F., Subbarao, K., Luke, C.J., Treanor, J.J., Ackerman, M.E., Brown, E.P., Housman, M.L., Khalenkov, A.M., Hoen, A.G., Haynes, B.C., Ilyushina, N.A., Journal of Infectious Diseases, 2015, 10.1093/infdis/jiu458

Systems biology of vaccination for seasonal influenza in humans, Pulendran, B., Ahmed, R., Subbarao, K., Aderem, A., Mehta, A.K., Elbein, R., Li, S., Kokko, K.E., Kanchan, V., McCausland, M., Li, G.-M., Khan, N., Kasturi, S.P., Means, A.R., Haining, W.N., Marie-Kunze, S., Racioppi, L., Lee, E.K., Wrammert, J., Nakaya, H.I., Nature Immunology, 2011, 10.1038/ni.2067

Evaluation of a genetically modified reassortant H5N1 influenza a virus vaccine candidate generated by plasmid-based reverse genetics, Matsuoka, Y., Cox, N., Katz, J., Lu, X., Xu, X., Brownlee, G., Fodor, E., Mingay, L., Swayne, D., Chen, H., Subbarao, K., Virology, 2003, 10.1006/viro.2002.1742

The contribution of animal models to the understanding of the host range and virulence of influenza A viruses, Subbarao, K., O'Donnell, C.D., Microbes and Infection, 2011, 10.1016/j.micinf.2011.01.014

Passive immunization with influenza haemagglutinin specific monoclonal antibodies, Kanta Subbarao, Rajeev Rudraraju, Human Vaccines & Immunotherapeutics, 2018, 10.1080/21645515.2018.1489947

Evaluation of novel influenza a viruses and their pandemic potential, Bridges, C.B., Subbarao, K., Pediatric Annals, 2000

A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice, Nabel, G.J., Subbarao, K., Murphy, B.R., Roberts, A., Huang, Y., Kong, W.-P., Yang, Z.-Y., Nature, 2004, 10.1038/nature02463

Prior Infection and Passive Transfer of Neutralizing Antibody Prevent Replication of Severe Acute Respiratory Syndrome Coronavirus in the Respiratory Tract of Mice, Murphy, B., Zaki, S., Shieh, W.-J., Packard, M., Tatti, K., Fischer, S., Fahle, G., Vogel, L., McAuliffe, J., Subbarao, K., Journal of Virology, 2004, 10.1128/JVI.78.7.3572-3577.2004

Genomic analysis reveals age-dependent innate immune responses to severe acute respiratory syndrome coronavirus, Subbarao, K., Katze, M.G., Tumpey, T.M., Chen, J., Vogel, L., Teal, T.H., Roberts, A., Baas, T., Journal of Virology, 2008, 10.1128/JVI.00489-08

Safety and immunogenicity of a cold–adapted influenza a (H1N1) reassortant virus vaccine administered to infants less than six months of age, Murphy, B.R., Fries, L.F., Clements, M.L., MaCleod, K., Wilson, M.H., Subbarao, E.K., Steinhoff, M.C., Karron, R.A., Pediatric Infectious Disease Journal, 1995

A single-amino-acid substitution in a polymerase protein of an H5N1 influenza virus is associated with systemic infection and impaired T-cell activation in mice, Subbarao, K., Katze, M.G., Proll, S., Cheng, L.I., Ward, J.M., Carter, V., Santos, C., Gillim-Ross, L., Fornek, J.L., Journal of Virology, 2009, 10.1128/JVI.00994-09

Immunogenicity and protective efficacy in mice and hamsters of a β-propiolactone inactivated whole virus SARS-CoV vaccine, Subbarao, K., Vassilev, V., Ward, J.M., Chen, J., Knott, I., Goossens, G., Baras, B., Vogel, L., Lamirande, E.W., Roberts, A., Viral Immunology, 2010, 10.1089/vim.2010.0028

Memory CD4 ⁺ T cells: Beyond "helper" functions, Subbarao, K., Boonnak, K., Journal of Clinical Investigation, 2012, 10.1172/JCI65208

Transcript of the question and answer sessions from the Fifth International Symposium on Avian Influenza, Marsh-Johnson, T., Preston, K., Hatkins, J., Byrd, C., Akey, B., Collins, R., Dybkaer, K., Perdue, M., Pasick, J., Spackman, E., Gonder, E., Fernandez, R., Tollis, M., Silim, A., Ehlers, M., Holt, P., Naeem, K., Erasmus, B., Cox, N., Anthony, C., Tam, G., Pittman, M., Kounev, Z., Pearson, J., Myers, T.J., Pharo, H., Rudd, K., Bright, R., Beard, C., Shirley, L., Schultz-Cherry, S., Marangon, S., Banks, J., Lu, H., Tumpey, T., Rowe, T., Matsuoka, Y., Katz, J., Swayne, D., Stohr, K., Bridge, C., Reid, A., Bublot, M., Perez, D.R., Webby, R., Koch, G., Lindstrom, S., Peiris, M., McCullers, J., Won Lee, C., Koch, G., Subbarao, K., Trock, S., Senne, D., Kawaoka, Y., O'Conner, R., Burns, K., Cattoli, G., Romero, C., Campitelli, L., Geale, D., Hanson, B., Webster, R., Karunakaran, D., Jestin, V., Kuhne, P.J.G., Van Der Goot, J., Henzler, D., Fouchier, R., Cardona, C., Brown, I., Halvorson, D., Miles, A., Suarez, D., Mutinelli, F., Trock, S., Michel, B., Capua, I., Sims, L., Glauer, D., Cutler, G., Slemons, R., Zanella, A., Donahoe, J., Alexander, D., Rivera, E., Naeem, K., Dunn, P., Eckroade, R., Kinde, H., Selleck, P., Perez, D., Woolcock, P., Swayne, D.E., Avian Diseases, 2003

Off‐target effects of bacillus Calmette–Guérin vaccination on immune responses to SARS‐CoV‐2: implications for protection against severe COVID‐19, Nigel Curtis, Kanta Subbarao, Suellen Nicholson, Melanie R Neeland, Laure F Pittet, Rhian Bonnici, Rajeev Rudraraju, Rebecca McElroy, Susie Germano, Nicole L Messina, Clinical & Translational Immunology, 2022, 10.1002/cti2.1387

Neutralizing antibody and protective immunity to SARS coronavirus infection of mice induced by a soluble recombinant polypeptide containing an N-terminal segment of the spike glycoprotein, Moss, B., Subbarao, K., Vogel, L., Roberts, A., Bisht, H., Virology, 2005, 10.1016/j.virol.2005.01.042

Vesicular stomatitis virus-based H5N1 avian influenza vaccines induce potent cross-clade neutralizing antibodies in rhesus macaques, Rose, J.K., Subbarao, K., Marx, P.A., Hunter, M., Suguitan Jr., A., Buonocore, L., Schwartz, J.A., Journal of Virology, 2011, 10.1128/JVI.02491-10

Prophylaxis with a Middle East Respiratory Syndrome Coronavirus (MERS-CoV)-Specific Human Monoclonal Antibody Protects Rabbits from MERS-CoV Infection, Subbarao, K., Dimitrov, D.S., Moore, I.N., Bock, K.W., Lamirande, E.W., Vogel, L., Wang, Y., Ying, T., Gretebeck, L., Houser, K.V., Journal of Infectious Diseases, 2016, 10.1093/infdis/jiw080

Animal models and antibody assays for evaluating candidate SARS vaccines: Summary of a technical meeting 25-26 August 2005, London, UK, Cherian, T., Wood, D., Ferguson, M., Subbarao, K., Wood, J., Roberts, A., Vaccine, 2006, 10.1016/j.vaccine.2006.07.009

The influence of the multi-basic cleavage site of the H5 hemagglutinin on the attenuation, immunogenicity and efficacy of a live attenuated influenza A H5N1 cold-adapted vaccine virus, Subbarao, K., Kemble, G., Swayne, D.E., Jin, H., Donis, R.O., Matsuoka, Y., Chen, L.-M., Desai, P.D., Marino, M.P., Suguitan Jr., A.L., Virology, 2009, 10.1016/j.virol.2009.09.017

Animal models for SARS and MERS coronaviruses, Subbarao, K., Gretebeck, L.M., Current Opinion in Virology, 2015, 10.1016/j.coviro.2015.06.009

Corrigendum to: "Receptor specificity does not affect replication or virulence of the 2009 pandemic H1N1 influenza virus in mice and ferrets" [Virology 446 (1-2) (2013) 349-356]doi: 10.1016/j.virol.2013.08.011, Subbarao, K., Sasisekharan, R., Paskel, M., Moore, I., Lamirande, E.W., Jayaraman, A., Shih, A.R., Lakdawala, S.S., Virology, 2015, 10.1016/j.virol.2015.11.010

A live attenuated H9N2 influenza vaccine is well tolerated and immunogenic in healthy adults, Subbarao, K., Murphy, B.R., Kemble, G., Jin, H., Coelingh, K., Joseph, T., Schappell, E., McAuliffe, J., Thumar, B., Luke, C., Callahan, K., Karron, R.A., Journal of Infectious Diseases, 2009, 10.1086/596558

Detection of multiple viral agents in nasopharyngeal specimens yielding Respiratory Syncytial Virus (RSV). An assessment of diagnostic strategy and clinical significance, Waner, J.L., Griffis, J., Subbarao, E.K., Diagnostic Microbiology and Infectious Disease, 1989, 10.1016/0732-8893(89)90098-9

Severity of clinical disease and pathology in ferrets experimentally infected with influenza viruses is influenced by inoculum volume, Subbarao, K., Qin, J., Donahue, D., Paskel, M., Lamirande, E.W., Moore, I.N., Journal of Virology, 2014, 10.1128/JVI.02341-14

B cell response and hemagglutinin stalk-reactive antibody production in different age cohorts following 2009 H1N1 influenza virus vaccination, Subbarao, K., Topham, D.J., Treanor, J.J., Wright, P.F., Zand, M.S., Luke, C.J., Yang, H., Krammer, F., Henn, A.D., Sundararajan, A., Ilyushina, N.A., Fitzgerald, T., Santiago, F.W., Baer, J., Sangster, M.Y., Clinical and Vaccine Immunology, 2013, 10.1128/CVI.00735-12

Induction of protective immunity against influenza A/Jiangxi-Donghu/346/2013 (H10N8) in mice, Lau, Y.-F., Subbarao, K., Lamirande, E., Sin, W.-L., Lim, J.-H., Sutton, T., Tang, L.-H., Kuah, L.-F., Journal of General Virology, 2017, 10.1099/jgv.0.000683

B cell response and hemagglutinin stalk-reactive antibody production in different age cohorts following 2009 H1N1 influenza virus vaccination., Subbarao, K., Topham, D.J., Treanor, J.J., Wright, P.F., Zand, M.S., Luke, C.J., Yang, H., Krammer, F., Henn, A.D., Sundararajan, A., Ilyushina, N.A., Fitzgerald, T., Santiago, F.W., Baer, J., Sangster, M.Y., Clinical and vaccine immunology : CVI, 2013

β-Microglobulin-deficient mice can be protected against influenza A infection by vaccination with vaccinia-influenza recombinants expressing hemagglutinin and neuraminidase, Murphy, B.R., Connors, M., Subbarao, E.K., Lawson, C.M., Misplon, J.A., Epstein, S.L., Journal of Immunology, 1993

Modelling the synergy between single-occupancy and PPE in controlling COVID-19 outbreaks on hospital wards, Nicholas Geard, Kanta Subbarao, Sheena Sullivan, Jason Monty, Kirsty Buising, Marion Kainer, Caroline Marshall, Robyn Schofield, Cameron Zachreson, 2024, 10.1101/2024.12.23.24319413

Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models, Miles P. Davenport, Stephen J. Kent, David H. O’Connor, Kanta Subbarao, Deborah Cromer, Arnold Reynaldi, Mitchell D. Ramuta, Adam K. Wheatley, David S. Khoury, Nature Reviews Immunology, 2020, 10.1038/s41577-020-00471-1

Influenza vaccines: Challenges and solutions, Subbarao, K., Houser, K., Cell Host and Microbe, 2015, 10.1016/j.chom.2015.02.012

Influenza a infections: From chickens to humans, Subbarao, K., Clinical Microbiology Newsletter, 2001, 10.1016/S0196-4399(01)89051-6

Improving pandemic H5N1 influenza vaccines by combining different vaccine platforms, Subbarao, K., Luke, C.J., Expert Review of Vaccines, 2014, 10.1586/14760584.2014.922416

A single amino acid in the PB2 gene of influenza A virus is a determinant of host range, Murphy, B.R., London, W., Subbarao, E.K., Journal of Virology, 1993

Therapy with a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody reduces disease severity and viral burden in golden Syrian hamsters, Ambrosino, D.M., Subbarao, K., Zaki, S., Sullivan, J.L., Hayes, N., Vogel, L., Greenough, T.C., Babcock, G.J., Lamirande, E.W., Guarner, J., Thomas, W.D., Roberts, A., Journal of Infectious Diseases, 2006, 10.1086/500143

Long-read RNA sequencing identifies polyadenylation elongation and differential transcript usage of host transcripts during SARS-CoV-2 in vitro infection, Lachlan J.M. Coin, Timothy P. Stinear, Kanta Subbarao, Michael B. Clark, Sarah L. Londrigan, Francesca L. Mordant, Chenxi Zhou, Ricardo De Paoli-Iseppi, Miranda E. Pitt, Daniel Rawlinson, Josie Gleeson, Jessie J.-Y. Chang, 2021, 10.1101/2021.12.14.472725

The contribution of systemic and pulmonary immune effectors to vaccine-induced protection from H5N1 influenza virus infection, Subbarao, K., Wright, A.R., Lau, Y.-F., Journal of Virology, 2012, 10.1128/JVI.07205-11

Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys, Subbarao, K., Murphy, B., St. Claire, M., Zaki, S., Butler, E., Shieh, W.-J., Fischer, S., Fahle, G., Roberts, A., Vogel, L., McAuliffe, J., Virology, 2004, 10.1016/j.virol.2004.09.030

A 12-Month-Interval Dosing Study in Adults Indicates That a Single Dose of the National Institute of Allergy and Infectious Diseases Tetravalent Dengue Vaccine Induces a Robust Neutralizing Antibody Response, Whitehead, S.S., Subbarao, K., Fraser, E.A., Walsh, M.C., Luke, C.J., Lovchik, J.M., Jo, M., Larsson, C.J., Sendra, E.A., McElvany, B.D., Sabundayo, B.P., Jarvis, A.P., Opert, K., Hynes, N., Grier, P.L., Tibery, C.M., Carmolli, M.P., Pierce, K.K., Kirkpatrick, B.D., Durbin, A.P., Journal of Infectious Diseases, 2016, 10.1093/infdis/jiw067

A general overview of viral vaccine development, Murphy, B.R., Subbarao, E.K., Advances in Experimental Medicine and Biology, 1992

Characterization of the surface proteins of influenza A (H5N1) viruses isolated from humans in 1997-1998, Subbarao, K., Lim, W., Cameron, K., Gregory, V., Hay, A., Cox, N., Klimov, A., Huang, J., Hall, H., Bender, C., Virology, 1999, 10.1006/viro.1998.9529

Evaluation of replication, immunogenicity and protective efficacy of a live attenuated cold-adapted pandemic H1N1 influenza virus vaccine in non-human primates, Subbarao, K., Vogel, L., Matsuoka, Y., Paskel, M., Boonnak, K., Vaccine, 2012, 10.1016/j.vaccine.2012.06.088

A live attenuated severe acute respiratory syndrome coronavirus is immunogenic and efficacious in Golden Syrian hamsters, Subbarao, K., Enjuanes, L., Baric, R., Zaki, S.R., Shieh, W.-J., Sheahan, T., Alvarez, E., Jackson, J.P., Roberts, A., DeDiego, M.L., Lamirande, E.W., Journal of Virology, 2008, 10.1128/JVI.00304-08

Receptor specificity does not affect replication or virulence of the 2009 pandemic H1N1 influenza virus in mice and ferrets, Subbarao, K., Sasisekharan, R., Paskel, M., Moore, I., Lamirande, E.W., Jayaraman, A., Shih, A.R., Lakdawala, S.S., Virology, 2013, 10.1016/j.virol.2013.08.011

Effective immunization with live attenuated influenza A virus can be achieved in early infancy, Wright, P.F., Wilson, M.H., Subbarao, K., Steinhoff, M.C., Murphy, B.R., Karron, R.A., Makhene, M.K., Clements, M.L., Journal of Infectious Diseases, 1996

Serologic screening, mass immunization, and implications for immunization programs [2], Kumar, M.L., Amin, S., Subbarao, E.K., Markowitz, L., Grabowsky, M., Journal of Infectious Diseases, 1991

A second external quality assessment of isolation and identification of influenza viruses in cell culture in the Asia Pacific region highlights improved performance by participating laboratories, Patrick C. Reading, Magdi Samaan, Francis Y. Inbanathan, Karen Nahapetyan, Ian G. Barr, Kanta Subbarao, Tasoula Zakis, Iwona Buettner, Heidi Peck, Angela Todd, Yi-Mo Deng, Vivian K.Y. Leung, Journal of Clinical Virology, 2021, 10.1016/j.jcv.2021.104907

Impact of glycosylation on the immunogenicity of a DNA-based influenza H5 HA vaccine, Katz, J.M., Robinson, H.L., Subbarao, K., Ross, T.M., Bright, R.A., Virology, 2003, 10.1016/S0042-6822(03)00008-4

Influenza A Virus Assembly Intermediates Fuse in the Cytoplasm, Subbarao, K., Shroff, H., Altan-Bonnet, N., Fodor, E., Lamirande, E.W., Broadbent, A.J., Kabat, J., Wawrzusin, P., Wu, Y., Lakdawala, S.S., PLoS Pathogens, 2014, 10.1371/journal.ppat.1003971

Attacking the flu: Neutralizing antibodies may lead to 'universal' vaccine, Subbarao, K., Chen, G.L., Nature Medicine, 2009, 10.1038/nm1109-1251

Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine, Lanzavecchia, A., Subbarao, K., Sallusto, F., Weiss, R.A., Temperton, N.J., Torres-Velez, F.J., Luke, C.J., Vanzetta, F., Santos, C., Fernandez-Rodriguez, B.M., Silacci, C., Pinna, D., Suguitan Jr., A.L., Corti, D., Journal of Clinical Investigation, 2010, 10.1172/JCI41902

Reassortment and evolution of current human influenza A and B viruses, Klimov, A., Cox, N.J., Subbarao, K., Mungall, B.A., Hall, H.E., Smith, C.B., Shaw, M.W., Lindstrom, S.E., Xu, X., Virus Research, 2004, 10.1016/j.virusres.2004.02.013

Influenza vaccine-live, Subbarao, K., Lakdawala, S.S., Luke, C.J., Vaccines: Sixth Edition, 2012, 10.1016/B978-1-4557-0090-5.00027-6

Predicting the evolution of human influenza A, Fitch, W.M., Cox, N.J., Subbarao, K., Bender, C.A., Bush, R.M., Science, 1999, 10.1126/science.286.5446.1921

Effect of priming with H1N1 influenza viruses of variable antigenic distances on challenge with 2009 pandemic H1N1 virus, Subbarao, K., Nabel, G.J., Wei, C.-J., Vogel, L.N., Wright, A., O'Donnell, C.D., Journal of Virology, 2012, 10.1128/JVI.00147-12

Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection, Wilson, P.C., Ahmed, R., Compans, R., Mulligan, M.J., Marasco, W.A., Subbarao, K., Yewdell, J.W., O'Donnell, C.D., Ranjan Das, S., Wang, Y., Rao Amara, R., Andrews, S., Kaur, K., Ali, Z., Huang, M., Lee, J.-H., Zheng, N.-Y., Del Rio, C., Razavi, B., Mehta, A., Lipkin, W.I., Hornig, M., Skountzou, I., McCausland, M., Morrissey, M., Sui, J., Edupuganti, S., Li, G.-M., Koutsonanos, D., Wrammert, J., Journal of Experimental Medicine, 2011, 10.1084/jem.20101352

The multibasic cleavage site of the hemagglutinin of highly pathogenic a/vietnam/1203/2004 (H5N1) avian influenza virus acts as a virulence factor in a host-specific manner in mammals, Subbarao, K., Orandle, M., Cheng, L.I., Vogel, L., Santos, C.P., Lau, Y.-F., Matsuoka, Y., Suguitan Jr., O.L., Journal of Virology, 2012, 10.1128/JVI.05546-11

Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcγRII-dependent entry into B cells in vitro, Altmeyer, R., Nal, B., Peiris, M., Subbarao, K., Zaki, S.R., Guarner, J., Tse, J., Chu, S.L., Vogel, L., Lamirande, E.W., Cheung, Y.C., Roberts, A., Kien, F., Kam, Y.W., Vaccine, 2007, 10.1016/j.vaccine.2006.08.011

Performance of rapid tests for detection of avian influenza A virus types H5N1 and H9N2 [3], Subbarao, K., McAuliffe, J.M., Nelson, N.A., Fedorko, D.P., Journal of Clinical Microbiology, 2006, 10.1128/JCM.44.4.1596-1597.2006

Encephalitis associated with influenza B virus infection in 2 children and a review of the literature, Subbarao, K., Safranek, T., Holst, A., Drake, C., Varman, M., Romero, J.R., Newland, J.G., Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2003

Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness, Cox, N., Fukuda, K., Xu, X., Shaw, M., Rowe, T., Hemphill, M., Huang, J., Bender, C., Swayne, D., Perdue, M., Hall, H., Lim, W., Regnery, H., Katz, J., Klimov, A., Subbarao, K., Science, 1998, 10.1126/science.279.5349.393

Humans and ferrets with prior H1N1 influenza virus infections do not exhibit evidence of original antigenic sin after infection or vaccination with the 2009 pandemic H1N1 influenza virus, Subbarao, K., Treanor, J.J., Boonnak, K., Vogel, L., Wright, A., O'Donnell, C.D., Clinical and Vaccine Immunology, 2014, 10.1128/CVI.00790-13

Influenza virus vaccines: Lessons from the 2009 H1N1 pandemic, Subbarao, K., Broadbent, A.J., Current Opinion in Virology, 2011, 10.1016/j.coviro.2011.08.002

Is there an ideal animal model for SARS?, Roberts, A., Subbarao, K., Trends in Microbiology, 2006, 10.1016/j.tim.2006.05.007

Prevalence of Neutralising Antibodies to HCoV-NL63 in Healthy Adults in Australia, Kirsten M. Spann, James S. McCarthy, Lia van der Hoek, Eileen V. Roulis, Bridget E. Barber, Siddhartha Mahanty, Kanta Subbarao, Sean A. Lynch, Viruses, 2021, 10.3390/v13081618

Predicting the efficacy of variant-modified COVID-19 vaccine boosters, Deborah Cromer, Miles P. Davenport, Stephen J. Kent, Kanta Subbarao, Steffen S. Docken, David S. Khoury, Nature Medicine, 2023, 10.1038/s41591-023-02228-4

Heterovariant cross-reactive B-cell responses induced by the 2009 pandemic influenza virus A subtype H1N1 vaccine, Greenberg, H.B., Subbarao, K., Dekker, C.L., Jin, H., Sangster, M.Y., Topham, D.J., Treanor, J.J., Golding, H., Khurana, S., Baer, J., Sasaki, S., He, X.-S., Journal of Infectious Diseases, 2013, 10.1093/infdis/jis664

Mechanisms of Heterosubtypic Immunity to Lethal Influenza A Virus Infection in Fully Immunocompetent, T Cell-Depleted, β2-Microglobulin-Deficient, and J Chain-Deficient Mice, Subbarao, K., Max, E.E., Hendrickson, B.A., Lawson, C.M., Misplon, J.A., Lo, C.-Y., Epstein, S.L., Journal of Immunology, 1997

Identification and characterization of severe acute respiratory syndrome coronavirus replicase proteins, Denison, M.R., Subbarao, K., Lu, X., McAuliffe, J., Prentice, E., Journal of Virology, 2004, 10.1128/JVI.78.18.9977-9986.2004

Evaluation of live attenuated influenza A virus H6 vaccines in mice and ferrets, Subbarao, K., Kemble, G., Jin, H., Gillim-Ross, L., Aspelund, A., Santos, C., Chen, Z., Journal of Virology, 2009, 10.1128/JVI.01775-08

Seasonal influenza infection and live vaccine prime for a response to the 2009 pandemic H1N1 vaccine, Subbarao, K., McCall, A.W., Lamirande, E.W., Lau, Y.-F., Chen, G.L., Proceedings of the National Academy of Sciences of the United States of America, 2011, 10.1073/pnas.1009908108

An influenza A live attenuated reassortant virus possessing three temperature-sensitive mutations in the PB2 polymerase gene rapidly loses temperature sensitivity following replication in hamsters, Subbarao, K., Gottlieb, P., Park, E.J., Murphy, B.R., Vaccine, 1997, 10.1016/S0264-410X(97)00031-5

Découvrez nos professeurs et professeures!

Kanta Subbarao

Contribution à la recherche

Thématiques de recherche de la Faculté de médecine

Domaines de recherche

Projets de recherche en cours

Financements des 2 dernières années

Publications

Vice-décanat à la recherche et à l'innovation